Reuters logo
BRIEF-Living Cell Technologies seeks trading halt
November 8, 2017 / 11:25 PM / 13 days ago

BRIEF-Living Cell Technologies seeks trading halt

Nov 9 (Reuters) - Living Cell Technologies Ltd:

* Seeks trading halt pending NTCELL’s Parkinson Disease clinical trial results announcement to ASX expected on Nov. 10, 2017 Source text for Eikon: Further company coverage: (bangalore.newsroom@thomsonreuters.com)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below